Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Fundamental & Clinical Pharmacology

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/fcp.12318PMID 28833476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.

  2017cited by this paper
• G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A

  2016cited by this paper
• Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.

  2016cited by this paper
• Cardiac remodelling and RAS inhibition

  2016cited by this paper
• AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress.

  2016cited by this paper
• Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling.

  2016cited by this paper
• ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.

  2016cited by this paper
• Protective role of ACE2-Ang-(1–7)-Mas in myocardial fibrosis by downregulating KCa3.1 channel via ERK1/2 pathway

  2016cited by this paper
• The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy.

  2016cited by this paper
• The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1–7) in a chronic atrial tachycardia canine model

  2016cited by this paper
• Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction

  2016cited by this paper
• Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure

  2015cited by this paper
• Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

  2015cited by this paper
• Pleiotropic Effects of Angiotensin II Receptor Signaling in Cardiovascular Homeostasis and Aging.

  2015cited by this paper
• Angiotensin‐(1‐7) Prevents Angiotensin II‐induced Fibrosis in Cremaster Microvessels

  2015cited by this paper
• Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction

  2015cited by this paper
• Mas receptor mediates cardioprotection of angiotensin‐(1‐7) against Angiotensin II‐induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress

  2015cited by this paper
• Blockade of KCa 3 . 1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction

  2015cited by this paper
• Effects of the angiotensin-(1-7)/Mas/PI3K/Akt/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model

  2015cited by this paper
• Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats.

  2015cited by this paper
• Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis

  2014cited by this paper
• Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease

  2014cited by this paper
• Angiotensin‐(1–7) attenuates angiotensin II‐induced signalling associated with activation of a tyrosine phosphatase in Sprague–Dawley rats cardiac fibroblasts

  2014cited by this paper
• The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review

  2013cited by this paper
• Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels

  2012cited by this paper
• Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?

  2012cited by this paper
• Possible mechanism of the cardio-renal protective effects of AVE-0991, a non-peptide Mas-receptor agonist, in diabetic rats

  2012cited by this paper
• Angiotensin-(1-9) Attenuates Cardiac Fibrosis in the Stroke-Prone Spontaneously Hypertensive Rat via the Angiotensin Type 2 Receptor

  2012cited by this paper
• Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.

  2012cited by this paper
• Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.

  2012cited by this paper
• Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart.

  2012cited by this paper
• Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor

  2012cited by this paper
• Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice.

  2012cited by this paper
• Epidemiology and risk profile of heart failure

  2011cited by this paper
• Aging and Cardiac Fibrosis.

  2011cited by this paper
• Angiotensin1‐9 antagonises pro‐hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

  2011cited by this paper
• Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart

  2010cited by this paper
• Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.

  2010cited by this paper
• Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.

  2010cited by this paper
• Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.

  2010cited by this paper
• PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy

  2010cited by this paper
• Lifetime Overproduction of Circulating Angiotensin-(1-7) Attenuates Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Dysfunction and Remodeling

  2010cited by this paper
• Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.

  2010cited by this paper
• Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro

  2010cited by this paper
• Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3′,5′-Cyclic Monophosphate–Dependent Pathway

  2010cited by this paper
• Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases.

  2009cited by this paper
• You can do more to slow the progression of heart failure.

  2009cited by this paper
• Cardiac fibroblasts: at the heart of myocardial remodeling.

  2009cited by this paper
• The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats.

  2008cited by this paper
• Selective increase of angiotensin(1–7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training

  2008cited by this paper
• Regulation of ACE2 in cardiac myocytes and fibroblasts.

  2008cited by this paper
• Distinct roles for angiotensin‐converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart

  2008cited by this paper
• Angiotensin‐(1–7) has a dual role on growth‐promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II‐stimulated ERK1/2 and Rho kinase activity

  2008cited by this paper
• Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

  2008cited by this paper
• Angiotensin metabolites can stimulate receptors of the Mas-related genes family

  2008cited by this paper
• Cross-Talk Between Mineralocorticoid and Angiotensin II Signaling for Cardiac Remodeling

  2008cited by this paper
• Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

  2008cited by this paper
• Angiotensin II-Stimulated Collagen Synthesis in Aortic Adventitial Fibroblasts Is Mediated by Connective Tissue Growth Factor

  2008cited by this paper
• Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats

  2007cited by this paper
• Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction.

  2007cited by this paper
• Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991.

  2007cited by this paper
• Cardiovascular-Renal Mechanisms in Health and Disease Prevention of angiotensin II-induced cardiac remodeling by angiotensin-( 1 – 7 )

  2007cited by this paper
• The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.

  2007cited by this paper
• Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

  2006cited by this paper
• ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

  2006cited by this paper
• Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

  2006cited by this paper
• Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

  2006cited by this paper
• Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart.

  2006cited by this paper
• Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.

  2005cited by this paper
• Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol.

  2005cited by this paper
• Mechanical Device–Based Methods of Managing and Treating Heart Failure

  2005cited by this paper
• Myocardial infarction increases ACE2 expression in rat and humans.

  2005cited by this paper
• Protection from angiotensin II‐induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats

  2005cited by this paper
• NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology

  2005cited by this paper
• Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats.

  2004cited by this paper
• Oxidative stress in heart failure. More than just damage.

  2003cited by this paper
• Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles: Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2

  2003cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.

  2003cited by this paper
• Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts.

  2003cited by this paper
• Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis

  2003cited by this paper
• Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

  2002cited by this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002cited by this paper
• Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts.

  2002cited by this paper
• AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium

  2002cited by this paper
• Angiotensin-(1-7): Cardioprotective Effect in Myocardial Ischemia/Reperfusion

  2001cited by this paper
• Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors

  2001cited by this paper
• Cardiac Angiotensin II Formation in the Clinical Course of Heart Failure and Its Relationship With Left Ventricular Function

  2001cited by this paper
• A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

  2000cited by this paper
• Induction of cardiac fibrosis by transforming growth factor-beta(1).

  2000cited by this paper
• Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study.

  2000cited by this paper
• Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition.

  1999cited by this paper
• Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor‐β1 in cardiac fibroblasts

  1999cited by this paper
• Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts.

  1997cited by this paper
• Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture.

  1994cited by this paper
• Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.

  1994cited by this paper
• Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression.

  1994cited by this paper
• In Vivo Metabolism of Angiotensin I by Neutral Endopeptidase (EC 3.4.24.11) in Spontaneously Hypertensive Rats

  1992cited by this paper
• Evidence that prolyl endopeptidase participates in the processing of brain angiotensin.

  1991cited by this paper
• Motion of the heart 1628 to 1982 and Beyond.

  1982cited by this paper

• Insight into novel therapeutic targets in heart failure: a comprehensive review

  2025cites this paper
• The relationship between estrogen and renin angiotensin system components in the context of hypertension

  2025cites this paper
• Novel Insights into the Cardioprotective Effects of the Peptides of the Counter-Regulatory Renin–Angiotensin System

  2024cites this paper
• Emerging roles of the renin-angiotensin system in select oral diseases.

  2024cites this paper
• Application of Compounds with Anti‐Cardiac Fibrosis Activity: A Review

  2024cites this paper
• Novel Strategies to Improve the Cardioprotective Effects of Cardioplegia

  2024cites this paper
• Genetic diet interactions of ACE: the increased hypertension predisposition in the Latin American population

  2023cites this paper
• Transcriptional Profiling of SARS-CoV-2-Infected Calu-3 Cells Reveals Immune-Related Signaling Pathways

  2023cites this paper
• Treatment of human cardiac fibroblasts with the protein arginine deiminase inhibitor BB-Cl-amidine activates the Nrf2/HO-1 signaling pathway.

  2023cites this paper
• Pathobiological bases of asthma-COVID-19 interaction: A theoretical viewpoint

  2023cites this paper
• Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy

  2022cites this paper
• A New Perspective on the Renin-Angiotensin System

  2022cites this paper
• Experimental heart failure models in small animals

  2022cites this paper
• Angiotensin-(1-9) in hypertension.

  2022cites this paper
• Role and interaction between ACE1, ACE2 and their related genes in cardiovascular disorders.

  2022cites this paper
• Protein nanoparticle-induced osmotic pressure gradients modify pulmonary edema through hyperpermeability in acute respiratory distress syndrome

  2022cites this paper
• Angiotensin-(3–7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways

  2021cites this paper
• Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system

  2021cites this paper
• Genetic and epigenetic control of ACE2 expression and its possible role in COVID‐19

  2021cites this paper
• Implication of RAS in Postnatal Cardiac Remodeling, Fibrosis and Dysfunction Induced by Fetal Undernutrition

  2021cites this paper
• Crosstalk between the renin-angiotensin system and the endoplasmic reticulum stress in the cardiovascular system: Lessons learned so far.

  2021cites this paper
• Angiotensin-converting enzyme 2 alleviates pulmonary artery hypertension through inhibition of focal adhesion kinase expression

  2021cites this paper
• Angiotensin-(1–7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice

  2021cites this paper
• Efficacy and safety of sacubitril-valsartan in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials

  2021cites this paper
• Pathophysiological and Clinical Evidence of the Effectiveness of Antioxidant Compounds as a Single or Adjunct Therapy for Hypertension

  2021cites this paper
• COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure

  2020cites this paper
• Is spironolactone the preferred renin-angiotensin-aldosterone inhibitor for protection against COVID-19?

  2020cites this paper
• Light-induced release of the cardioprotective peptide angiotensin-(1-9) from thermosensitive liposomes with gold nanoclusters.

  2020cites this paper
• Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

  2020cites this paper
• COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?

  2020cites this paper
• Sex differences in circulating proteins in heart failure with preserved ejection fraction

  2020cites this paper
• Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia–reperfusion necrosis in rats

  2020cites this paper
• Revealing the synergistic mechanism of Shenfu Decoction for anti-heart failure through network pharmacology strategy.

  2020cites this paper
• Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications

  2020cites this paper
• Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?

  2019cites this paper
• Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1–7

  2019cites this paper
• The opposite effects of angiotensin 1-9 and angiotensin 3-7 in prostate epithelial cells.

  2019cites this paper
• Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.

  2019cites this paper
• Effect of angiotensin-( 1-7 ) on vascular endothelial cell function and correlation with blood pressure variability in patients with secondary hypertension

  2019cites this paper
• Plasma and tissue angiotensin‐converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease

  2019cites this paper
• Novel Medical Treatments for Hypertension and Related Comorbidities

  2018cites this paper